Review and Analysis of 10-Year Data on China's Pharmaceutical Industry and Development Suggestions
Objective To summarize the development trend and current status of China's pharmaceutical industry.Methods The multiple national pharmaceutical industry-related yearbooks published from 2022 to 2024 were searched,as well as the relevant information in the official website of the National Medical Products Administration,the Support System for China Statistics Application and the Pharmacodia database.Based on the overall overview,circulation,usage fields,innovative development,and structural adjustment of China's pharmaceutical industry,the development of this industry from 1996 to 2022(especially from 2011 to 2022)was analyzed from the quantity and quality of high-quality development in related industries such as pharmaceutical manufacturing and medical device manufacturing,and targeted development suggestions were proposed.Results China's pharmaceutical manufacturing and medical device manufacturing industries had a certain number of enterprises,workers,products and fixed assets in terms of quantity structure of industrial development,and showed a good development trend in the innovative development,technology market,investment,financing and technology structure in terms of quality structure of industrial development.Conclusion The overall development of China's pharmaceutical industry is positive,and the current development is good.In order to further promote the high-quality development of the industry,it is suggested that we should optimize the regulatory service mechanism for drugs and medical devices,improve the modern drug circulation system,enhance the supply guarantee capability of drugs and medical devices,increase the supports for original innovation and key technology research,strengthen the organizational(management)innovation and marketing innovation capability and level,etc.
Chinapharmaceutical industryinnovationhigh-quality developmentyearbook data
万方数据
维普
